Development of Clinical Pharmcokinetics Service for Amikacin in Pediatric Cancer Patients

NERMEEN NABIL AHMED;

Abstract


Fever in an immune compromized neutropenic patient can lead to serious morbidity and mortality (Rubin R.H., et al. 1988). Rapid deterioration and death can occur due to bacterial sepsis. This fear led to the establishment of the practice of starting empir


Other data

Title Development of Clinical Pharmcokinetics Service for Amikacin in Pediatric Cancer Patients
Authors NERMEEN NABIL AHMED
Keywords Development of Clinical Pharmcokinetics Service for Amikacin in Pediatric Cancer Patients
Issue Date 2000
Description 
Fever in an immune compromized neutropenic patient can lead to serious morbidity and mortality (Rubin R.H., et al. 1988). Rapid deterioration and death can occur due to bacterial sepsis. This fear led to the establishment of the practice of starting empir

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.